Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-018384
Filing Date
2020-09-28
Accepted
2020-09-25 18:34:21
Documents
55
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 484898
2 ex31-1.htm EX-31.1 10645
3 ex31-2.htm EX-31.2 10599
4 ex32-1.htm EX-32.1 4915
5 ex32-2.htm EX-32.2 4429
  Complete submission text file 0001493152-20-018384.txt   2722211

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bdgy-20200630.xml EX-101.INS 340413
7 XBRL SCHEMA FILE bdgy-20200630.xsd EX-101.SCH 48288
8 XBRL CALCULATION FILE bdgy-20200630_cal.xml EX-101.CAL 51878
9 XBRL DEFINITION FILE bdgy-20200630_def.xml EX-101.DEF 122364
10 XBRL LABEL FILE bdgy-20200630_lab.xml EX-101.LAB 283872
11 XBRL PRESENTATION FILE bdgy-20200630_pre.xml EX-101.PRE 194475
Mailing Address 1015 15TH STREET NW SUITE 1030 WASHINGTON, DC DC 20005
Business Address 1015 15TH STREET NW SUITE 1030 WASHINGTON, DC DC 20005 972-525-8546
BRIDGEWAY NATIONAL CORP. (Filer) CIK: 0001567771 (see all company filings)

EIN.: 455523835 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55505 | Film No.: 201201478
SIC: 2860 Industrial Organic Chemicals